Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study.
Hudis C, Fornier M, Riccio L, Lebwohl D, Crown J, Gilewski T, Surbone A, Currie V, Seidman A, Reichman B, Moynahan M, Raptis G, Sklarin N, Theodoulou M, Weiselberg L, Salvaggio R, Panageas KS, Yao TJ, Norton L. Hudis C, et al. Among authors: crown j. J Clin Oncol. 1999 Apr;17(4):1118. doi: 10.1200/JCO.1999.17.4.1118. J Clin Oncol. 1999. PMID: 10561169 Clinical Trial.
Chemotherapy of metastatic Merkel cell cancer.
Crown J, Lipzstein R, Cohen S, Goldsmith M, Wisch N, Paciucci PA, Silverman L, Weiner M, Jaffrey I, Norton L, et al. Crown J, et al. Cancer Invest. 1991;9(2):129-32. doi: 10.3109/07357909109044222. Cancer Invest. 1991. PMID: 1863871 Review.
High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J, Vahdat L, Fennelly D, Francis P, Wasserheit C, Hudis C, Kritz A, Schneider J, Hamilton N, Gilewski T, et al. Crown J, et al. Ann N Y Acad Sci. 1993 Nov 30;698:378-88. doi: 10.1111/j.1749-6632.1993.tb17230.x. Ann N Y Acad Sci. 1993. PMID: 7506505 Review.
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.
Reichman BS, Seidman AD, Crown JP, Heelan R, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, et al. Reichman BS, et al. Among authors: crown jp. Ann N Y Acad Sci. 1993 Nov 30;698:398-402. doi: 10.1111/j.1749-6632.1993.tb17232.x. Ann N Y Acad Sci. 1993. PMID: 7506506 Clinical Trial. No abstract available.
366 results